Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
Dune Medical Launches US FDA Cleared Clinical Trial For Use Of MarginProbe In Breast Cancer Surgery
http://www.medicalnewstoday.com/articles/127139.php
Dune Medical Devices, Ltd. today announced the launch of a pivotal clinical trial of the MarginProbe™ intraoperative, real-time, positive margin detection system, following U.S. Food and Drug Administration (FDA) investigational device exemption (IDE) approval of its protocol during breast cancer surgery.
Department Of Health Research Shows Women Are Unaware Of Link Between Alcohol And Breast Cancer Risk
http://www.medicalnewstoday.com/articles/127053.php
New research from the Department of Health's Know Your Limits campaign reveals that the vast majority of UK women (82%) don't realise alcohol consumption can increase the risk of developing breast cancer.
Breakthrough Breast Cancer's Response To Better Cancer Care, UK
http://www.medicalnewstoday.com/articles/127051.php
Audrey Birt, Breakthrough Breast Cancer's Director for Scotland says: "Breakthrough Breast Cancer welcomes the publication today of Better Cancer Care. It's now essential that clear plans are put in place to ensure the recommendations in this report are implemented as soon as possible.
----------------------------------------------
** CANCER / ONCOLOGY News **
"Cancer Research" Journal Publishes Successful Angiogenesis Study Using Optimata's Technology
http://www.medicalnewstoday.com/articles/127178.php
Optimata Ltd., developer of the proprietary Optimata Virtual Patient® technology to navigate drug development, announced today that a scientific paper based on research carried out by company scientists will be published in the prestigious <i>"Cancer Research"</i> Journal 2008; edition 68: (21), on November, 1st 2008.
Enzon's HIF-1 Alpha Antagonist Shows Antitumor Activity
http://www.medicalnewstoday.com/articles/127172.php
Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) presented data from its pipeline programs at the 2008 EORTC-NCI-AACR (European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research) annual meeting in Geneva, Switzerland.
November Is Pancreatic Cancer Awareness Month
http://www.medicalnewstoday.com/articles/127087.php
According to the American Cancer Society (ACS), pancreatic cancer is the fourth leading cancer killer in the country, with over 37,000 new cases expected and more than 34,000 deaths by year's end.
Don't Forget The Men In October's Sea Of Pink
http://www.medicalnewstoday.com/articles/127078.php
Pink is all the rage in October as money and awareness are raised for the most common cancer for women (other than skin cancer) during Breast Cancer Awareness month. But what about some attention for one of the most common cancers in men? Prostate cancer is the second leading cause of cancer death in men, according to the American Cancer Society.
Health Communication For At-Risk Populations
http://www.medicalnewstoday.com/articles/127074.php
Health Literacy Month, recognized in October, promotes the importance of ensuring access to understandable health information. According to the National Assessment of Adult Literacy, only 12 percent of adults have proficient health literacy - skills needed to manage their health.
That 'Sticky' Chromosomes Have Role In Kidney Cancer, VAI Researchers Find - Somatic Chromosome Pairing May Play Role In Other Cancers As Well
http://www.medicalnewstoday.com/articles/127059.php
Van Andel Institute (VAI) researchers have found that when chromosomes "stick" together during the cell division process, an outcome known as somatic chromosome pairing, the result in two types of kidney cancer is disruption of a gene critical for cellular response to changes in oxygen levels.
Sunesis Announces Updated Clinical Data Of Voreloxin In Platinum-Resistant Ovarian Cancer
http://www.medicalnewstoday.com/articles/127015.php
Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) announced a presentation of updated interim results from an ongoing Phase 2 clinical trial demonstrating that the Company's lead product candidate, voreloxin, shows promising efficacy and safety as a single agent in patients with platinum-resistant ovarian cancer.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
British MDs Favor Gardasil For Own Children Despite Government Coverage Of Cervarix
http://www.medicalnewstoday.com/articles/127101.php
<BR >Many British doctors are choosing <A href="http://www.merck.com/" target=_new>Merck</A>'s human papillomavirus vaccine Gardasil for their own children over <A href="http://www.gsk.com/" target=_new>GlaxoSmithKline</A>'s Cervarix, which was selected by for coverage through Britain's National Health Service, according to a comment by Phil Hammond, a British doctor and media broadcaster, published Friday in the <CITE>British Medical Journal</CITE>, <A href="http://www.
----------------------------------------------
** COLORECTAL CANCER News **
PhytoMedical's In Vivo Toxicity And Efficacy Tests On Human Colon Cancer Deliver Promising Results
http://www.medicalnewstoday.com/articles/127144.php
PhytoMedical Technologies, Inc. (OTCBB: PYTO) (FWB: ET6), today announced the results of its anti-cancer compound in vivo toxicity and efficacy tests on HCT116 human colon cancer cells was successful.
----------------------------------------------
** LUNG CANCER News **
No news for this category today.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
The MDS Foundation Supports Vidaza's Recommendation For European Approval
http://www.medicalnewstoday.com/articles/127136.php
The Myelodysplastic Syndromes (MDS) Foundation supports the positive opinion from the European Union's Committee for Medicinal Products for Human Use (CHMP) recommending approval of VIDAZA (azacitidine) for specific types of MDS patients, including those with high-risk MDS, chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
Prostate Cancer Risk Did Not Reduce With Vitamin E And Selenium
http://www.medicalnewstoday.com/articles/127196.php
An initial independent review of data from a study looking at whether selenium and vitamin E supplements prevented prostate cancer found they had no benefit, taken either together or alone.The review of data from the Selenium and Vitamin E Cancer Prevention Trial (SELECT) was funded by the National Cancer Institute (NCI) in the US and other institutes from the National Institutes of Health in the US.
Don't Forget The Men In October's Sea Of Pink
http://www.medicalnewstoday.com/articles/127078.php
Pink is all the rage in October as money and awareness are raised for the most common cancer for women (other than skin cancer) during Breast Cancer Awareness month. But what about some attention for one of the most common cancers in men? Prostate cancer is the second leading cause of cancer death in men, according to the American Cancer Society.
PCA3 Test May Help Distinguish Aggressive Prostate Cancer
http://www.medicalnewstoday.com/articles/127056.php
The number of prostate cancer cases is increasing rapidly. Fortunately not all these tumours need to be operated - some are slow growing or indolent. The question remains: how do we reliably establish which tumour is aggressive and which is not? The answer may well be given by the PCA3 (Prostate Cancer Gene 3) test, a breakthrough in the diagnosis of prostate cancer.
Doctors Test Advanced Tool For Treating Prostate Cancer
http://www.medicalnewstoday.com/articles/127019.php
Leading radiation oncologists are using the TargetScan Touch(TM) system to deliver radioactive seed therapy in the prostate. The innovative technology is based on a motionless probe which stabilizes the prostate during procedures.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment